Critical Comparison: SeaStar Medical (NASDAQ:ICU) & NeuroOne Medical Technologies (NASDAQ:NMTC)

SeaStar Medical (NASDAQ:ICUGet Free Report) and NeuroOne Medical Technologies (NASDAQ:NMTCGet Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Valuation & Earnings

This table compares SeaStar Medical and NeuroOne Medical Technologies’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SeaStar Medical N/A N/A -$26.23 million ($25.00) -0.16
NeuroOne Medical Technologies $1.95 million 11.64 -$11.86 million ($0.58) -1.41

NeuroOne Medical Technologies has higher revenue and earnings than SeaStar Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

SeaStar Medical has a beta of -1.03, suggesting that its share price is 203% less volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.

Profitability

This table compares SeaStar Medical and NeuroOne Medical Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SeaStar Medical N/A N/A -725.48%
NeuroOne Medical Technologies -343.55% -277.71% -204.28%

Analyst Recommendations

This is a summary of current recommendations and price targets for SeaStar Medical and NeuroOne Medical Technologies, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical 0 0 0 0 N/A
NeuroOne Medical Technologies 0 0 1 0 3.00

NeuroOne Medical Technologies has a consensus price target of $2.20, indicating a potential upside of 169.81%. Given NeuroOne Medical Technologies’ higher probable upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than SeaStar Medical.

Insider and Institutional Ownership

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 3.0% of SeaStar Medical shares are owned by company insiders. Comparatively, 7.5% of NeuroOne Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

NeuroOne Medical Technologies beats SeaStar Medical on 9 of the 12 factors compared between the two stocks.

About SeaStar Medical

(Get Free Report)

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

About NeuroOne Medical Technologies

(Get Free Report)

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.